Uxin (UXIN) EBT (2017 - 2026)

Uxin (UXIN) has reported EBT for 10 consecutive years, with -$13.3 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, EBT fell 87.6% year-over-year to -$13.3 million; the trailing twelve-month figure through Mar 2026 stood at -$43.1 million (up 14.44% YoY), and the FY2025 full-year result was -$37.5 million, up 19.08% from the prior year.
• EBT fell to -$13.3 million in Q1 2026 per UXIN's latest filing, from -$11.8 million in the prior quarter.
• Across five years, EBT topped out at $57.0 million in Q1 2022 and bottomed at -$27.6 million in Q4 2024.
• Historically, EBT has averaged -$6.4 million across 5 years, with a median of -$11.0 million in 2023.
• The sharpest annual moves came in 2022 and 2023: EBT jumped 377.98% in 2022, then plunged 159.64% in 2023.
• Over 5 years, EBT stood at -$14.6 million in 2022, then gained by 24.73% to -$11.0 million in 2023, then sank by 151.31% to -$27.6 million in 2024, then jumped by 57.16% to -$11.8 million in 2025, then declined by 12.19% to -$13.3 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$13.3 million, -$11.8 million, and -$8.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.